Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

IRADIMED CORPORATION (IRMD) Profit Margins

Over the twelve months to 2026-06-30, IRADIMED CORPORATION (IRMD) had gross margin 75.9%, operating margin 31.9%, net margin 26.7%, free cash flow margin 28.3%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

IRMDIRADIMED CORPORATIONFollow IRMD — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
1.1B
P/E TTM
47.9
Dividend yield
0.9%
52-week
—
Next earnings
29 Oct, in 5 days
LineFY2014
Dec 14
FY2015
Dec 15
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin78.3%81.5%81.1%75.9%76.3%77.1%74.3%76.6%77.4%76.5%76.9%76.7%75.9%
Operating margin19.6%36.4%33.6%5.6%19.7%22.5%-2.4%23.5%29.3%30.6%30.0%31.2%31.9%
Net margin13.1%23.8%22.2%2.2%20.7%25.0%4.3%22.3%24.1%26.2%26.3%26.8%26.7%
FCF margin12.6%23.2%24.3%11.2%23.4%25.3%16.3%25.2%15.3%8.3%22.9%19.7%28.3%

USD millions · SEC XBRL

IRADIMED CORPORATION — questions

What is IRADIMED CORPORATION's gross margin?
75.9% over the twelve months to 2026-06-30.
What is IRADIMED CORPORATION's operating margin?
31.9% over the twelve months to 2026-06-30.
What is IRADIMED CORPORATION's net profit margin?
26.7% over the twelve months to 2026-06-30.

Every figure on this page comes from IRADIMED CORPORATION's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.